Biocon Biologics is a medical company that develops biosimilars. It offers spanning recombinant human Insulin (rh-Insulin), insulin analogs, monoclonal antibodies, and other recombinant proteins for the treatment of diabetes, cancer, autoimmune conditions, and other life-threatening diseases.
|Goldman Sachs, Tata Capital, True North|
Biocon Biologics has 2.43k Twitter Followers. The number of followers has increased 18.1% month over month and increased 48.2% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Biocon Biologics founded?
Biocon Biologics was founded in 1978.
How many employees does Biocon Biologics have?
Biocon Biologics has 1,286 employees.
Who are Biocon Biologics competitors?
Competitors of Biocon Biologics include Balmes Transplantation, BioFactura and CF PharmTech.
Receive alerts for 300+ data fields across thousands of companies